An Act relative to prescription drug price transparency
By Mr. Jones of North Reading, a petition (accompanied by bill, House, No. 1167) of Bradley H. Jones, Jr. and others that the Health Policy Commission and health insurers create listings of certain high cost prescription drugs and that the Attorney General require drug manufacturers to provide information to justify increases in costs. Health Care Financing.
Bill Information
Bill Information
- Presenter:
- Bradley H. Jones, Jr.
- Status:
- Referred to Joint Committee on Health Care Financing
Bill History
| Date | Branch | Action |
|---|---|---|
| 1/22/2019 | House | Referred to the committee on Health Care Financing |
| 1/22/2019 | Senate | Senate concurred |
| 3/27/2019 | Joint | Hearing scheduled for 04/11/2019 from 01:00 PM-04:00 PM in A-1 |
| 3/23/2020 | House | Reporting date extended to Friday May 1, 2020, pending concurrence |
| 3/26/2020 | Senate | Senate concurred |
| 4/29/2020 | House | Reporting date extended to Friday June 19, 2020, pending concurrence |
| 4/30/2020 | Senate | Senate concurred |
| 6/22/2020 | House | Reporting date extended to Thursday December 31, 2020, pending concurrence |
| 1/5/2021 | House | No further action taken |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.